| | | | | | | | Welcome to Editors' (re)View where the Pharma Manufacturing editors handpick notable pharma world happenings that deserve some extra consideration. See what you may have missed this week in pharma. |
|
|
|
| |
| | |
|
|
| | | | | Second time's a charm for Amneal, with the drugmaker winning approval for Crexont, a combo of immediate-release granules and extended-release pellets. |
|
|
| The potential $1.3 billion deal involves an early-stage asset for the treatment of B-cell associated diseases. |
|
|
|
| |
| | |
|
|
| | | | | The Pharma Innovation Awards are a celebration of technologies contributing to advancements in quality, efficiency and risk reduction. Did your company launch a product during the past year that's a game-changer for pharma manufacturers? Submit using our easy online form; deadline is August 9. |
|
|
|
| |
| | |
|
|
| | | | | The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing's print and online coverage. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
